{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T06:04:33Z","timestamp":1789452273292,"version":"build-2803163510"},"reference-count":50,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:00:00Z","timestamp":1789430400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Laryngeal squamous cell carcinoma (LSCC) remains a major cause of cancer-related mortality among head and neck malignancies. The tumor immune microenvironment plays a critical role in determining disease outcome; however, the specific immune cell composition and its prognostic relevance in LSCC have not been fully elucidated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>CIBERSORT was applied to bulk RNA-sequencing data from 381 TCGA-HNSCC samples to estimate the relative fractions of 22 immune cell types. LSCCs (n = 64) were selected for in-depth analyses. Consensus clustering based on immune profiles stratified patients into three clusters. Differentially expressed genes (DEGs) and pathway enrichment analyses were performed between Cluster 1 (immune-desert) and Clusters 2 &amp;amp; 3 (immune-active). Kaplan\u2013Meier survival analysis was used for prognostic assessment. YWHAG protein expression was evaluated by immunohistochemistry in an independent institutional cohort of patients with LSCC (n = 23), and its correlation with clinicopathological parameters was examined.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Across HNSCC subsites, LSCC tumors exhibited significantly higher infiltration of naive B cells and plasma cells than tumors from other anatomical sites (Kruskal-Wallis test, adjusted\n                      <jats:italic>P<\/jats:italic>\n                      &amp;lt; 0.05). Consensus clustering of LSCC identified three distinct immune profiles: Cluster 1 (immune-desert, dominated by M0 macrophages and eosinophils), Cluster 2 (immune-hot, enriched for B cells, plasma cells, and CD8+ T cells), and Cluster 3 (mixed-inflammatory). Tertiary lymphoid structure (TLS)-related genes were uniformly and significantly downregulated in Cluster 1 (\n                      <jats:italic>P<\/jats:italic>\n                      &amp;lt; 0.05). Furthermore, pathway analysis revealed that B cell-related pathways were significantly suppressed in Cluster 1. DEG analysis within Stage I\u2013III tumors revealed\n                      <jats:italic>YWHAG<\/jats:italic>\n                      as the sole gene significantly upregulated in Cluster 1. High\n                      <jats:italic>YWHAG<\/jats:italic>\n                      expression was associated with significantly shorter overall survival across all stages (log-rank\n                      <jats:italic>P<\/jats:italic>\n                      &amp;lt; 0.05). In the institutional immunohistochemistry cohort, strong YWHAG staining was significantly associated with larger tumor size.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      LSCC harbors distinct immune microenvironmental subtypes. Tumors enriched for B cell- and TLS- related gene signatures demonstrate favorable outcomes, whereas immune-desert tumors with elevated\n                      <jats:italic>YWHAG<\/jats:italic>\n                      expression are associated with poor prognosis. YWHAG expression may be associated with unfavorable outcomes, possibly due to reduced antitumor immune responses and increased tumor size.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1936961","type":"journal-article","created":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T05:35:53Z","timestamp":1789450553000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["YWHAG overexpression correlates with an immune-desert microenvironment and poor prognosis in laryngeal squamous cell carcinoma"],"prefix":"10.3389","volume":"17","author":[{"given":"Naoto","family":"Adachi","sequence":"first","affiliation":[{"name":"Department of Otorhinolaryngology Head and Neck Surgery, University of Fukui","place":["Fukui, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Sonoda","sequence":"additional","affiliation":[{"name":"Department of Otorhinolaryngology Head and Neck Surgery, University of Fukui","place":["Fukui, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fusako","family":"Takezawa","sequence":"additional","affiliation":[{"name":"Department of Otorhinolaryngology Head and Neck Surgery, University of Fukui","place":["Fukui, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukihiro","family":"Kimura","sequence":"additional","affiliation":[{"name":"Department of Otorhinolaryngology Head and Neck Surgery, University of Fukui","place":["Fukui, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shohei","family":"Higuchi","sequence":"additional","affiliation":[{"name":"Department of Pathology, Faculty of Medical Sciences, University of Fukui","place":["Fukui, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yohei","family":"Sato","sequence":"additional","affiliation":[{"name":"Department of Otorhinolaryngology Head and Neck Surgery, University of Fukui","place":["Fukui, Japan"]},{"name":"Immunology and Allergy Research Unit, Department of Otorhinolaryngology Head and Neck Surgery, University of Fukui","place":["Fukui, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masafumi","family":"Kanno","sequence":"additional","affiliation":[{"name":"Department of Otorhinolaryngology Head and Neck Surgery, University of Fukui","place":["Fukui, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeharu","family":"Fujieda","sequence":"additional","affiliation":[{"name":"Department of Otorhinolaryngology Head and Neck Surgery, University of Fukui","place":["Fukui, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1213716","article-title":"Recent advances and future perspectives of CAR-T cell therapy in head and neck cancer","volume":"14","author":"Hu","year":"2023","journal-title":"Front Immunol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1002\/hed.21613","article-title":"Current trends in initial management of hypopharyngeal cancer: The declining use of open surgery","volume":"34","author":"Takes","year":"2012","journal-title":"Head Neck"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines14050959","article-title":"Metabolism and metabolic reprogramming in laryngeal squamous cell carcinoma","volume":"14","author":"Verro","year":"2026","journal-title":"Biomedicines"},{"key":"B5","doi-asserted-by":"publisher","first-page":"19125","DOI":"10.1038\/s41598-026-50352-1","article-title":"High expression of STAT3 and PD-L1 predicts poor prognosis for laryngeal squamous cell carcinoma","volume":"16","author":"Shui","year":"2026","journal-title":"Sci Rep"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)32591-7","article-title":"Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study","volume":"394","author":"Burtness","year":"2019","journal-title":"Lancet"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-25-3377","article-title":"Molecular and immune landscape of recurrent and\/or distant metastatic squamous cell carcinoma of the head and neck: an EORTC\/IMMUCAN project","author":"van Der Elst","year":"2026","journal-title":"Clin Cancer Res"},{"key":"B8","doi-asserted-by":"publisher","first-page":"4228","DOI":"10.1038\/s41467-025-59341-w","article-title":"Mature tertiary lymphoid structures evoke intra-tumoral T and B cell responses via progenitor exhausted CD4+ T cells in head and neck cancer","volume":"16","author":"Li","year":"2025","journal-title":"Nat Commun"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-19-2929","article-title":"Early hepatic lesions display immature tertiary lymphoid structures and show elevated expression of immune inhibitory and immunosuppressive molecules","volume":"26","author":"Meylan","year":"2020","journal-title":"Clin Cancer Res"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2026.1778251","article-title":"Tumor immune microenvironment in non-small cell lung cancer progression","volume":"17","author":"Jiang","year":"2026","journal-title":"Front Immunol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1111\/cas.70205","article-title":"Variation of gene expression and methylation profiling in gingival and tongue cancers","volume":"116","author":"Kashiwagi","year":"2025","journal-title":"Cancer Sci"},{"key":"B12","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s12929-023-00953-z","article-title":"Circulating tumour DNA alterations: emerging biomarker in head and neck squamous cell carcinoma","volume":"30","author":"Huang","year":"2023","journal-title":"J BioMed Sci"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2024.189138","article-title":"Immunotherapy for HPV negative head and neck squamous cell carcinoma","volume":"1879","author":"Jiang","year":"2024","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1002\/lary.22133","article-title":"Infiltrating lymphocytes and human papillomavirus\u201016\u2013associated oropharyngeal cancer","volume":"122","author":"Wansom","year":"2012","journal-title":"Laryngoscope"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1596583","article-title":"Advances and challenges in immunotherapy in head and neck cancer","volume":"16","author":"Aboaid","year":"2025","journal-title":"Front Immunol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1038\/nmeth.3337","article-title":"Robust enumeration of cell subsets from tissue expression profiles","volume":"12","author":"Newman","year":"2015","journal-title":"Nat Methods"},{"key":"B17","doi-asserted-by":"publisher","first-page":"2528","DOI":"10.1038\/s41467-024-46873-w","article-title":"Tertiary lymphoid structures and B cells determine clinically relevant T cell phenotypes in ovarian cancer","volume":"15","author":"Kasikova","year":"2024","journal-title":"Nat Commun"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.6c05908","article-title":"Tailored biomaterials induce tertiary lymphoid structures for boosting cancer immunotherapy","volume":"20","author":"Wang","year":"2026","journal-title":"ACS Nano"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2026.117496","article-title":"Nerve-proximal tertiary lymphoid structures predict chemotherapy sensitivity in pancreatic cancer","volume":"45","author":"Cai","year":"2026","journal-title":"Cell Rep"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1439413","article-title":"The role of dendritic cells in tertiary lymphoid structures: implications in cancer and autoimmune diseases","volume":"15","author":"Reste","year":"2024","journal-title":"Front Immunol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-019-0144-6","article-title":"Tertiary lymphoid structures in the era of cancer immunotherapy","volume":"19","author":"Saut\u00e8s-Fridman","year":"2019","journal-title":"Nat Rev Cancer"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.R100059200","article-title":"14-3-3 Proteins: active cofactors in cellular regulation by serine\/threonine phosphorylation","volume":"277","author":"Tzivion","year":"2002","journal-title":"J Biol Chem"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2025.112139","article-title":"YWHAG mediated epithelial-mesenchymal transition facilitates tumor progression and metastatic spread in non-small cell lung cancer","volume":"136","author":"Liu","year":"2025","journal-title":"Cell Signal"},{"key":"B24","doi-asserted-by":"publisher","first-page":"203","DOI":"10.3892\/mmr.2022.12719","article-title":"TXNDC9 knockdown inhibits lung adenocarcinoma progression by targeting YWHAG","volume":"25","author":"Wang","year":"2022","journal-title":"Mol Med Rep"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.21873\/anticanres.12622","article-title":"Knockdown of 14-3-3\u03b3 suppresses epithelial\u2013mesenchymal transition and reduces metastatic potential of human non-small cell lung cancer cells","volume":"38","author":"Raungrut","year":"2018","journal-title":"Anticancer Res"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1007\/s00204-020-02782-7","article-title":"Functional genetic variants in centrosome-related genes CEP72 and YWHAG confer susceptibility to gastric cancer","volume":"94","author":"Ni","year":"2020","journal-title":"Arch Toxicol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2017.244","article-title":"Elevation of adenylate energy charge by angiopoietin-like 4 enhances epithelial\u2013mesenchymal transition by inducing 14-3-3\u03b3 expression","volume":"36","author":"Teo","year":"2017","journal-title":"Oncogene"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-07-0090","article-title":"Up-regulation of 14-3-3\u03b6 in lung cancer and its implication as prognostic and therapeutic target","volume":"67","author":"Fan","year":"2007","journal-title":"Cancer Res"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.20492","article-title":"Isoform\u2010specific expression of 14\u20103\u20103 proteins in human lung cancer tissues","volume":"113","author":"Qi","year":"2005","journal-title":"Int J Cancer"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1914-8","article-title":"Tertiary lymphoid structures improve immunotherapy and survival in melanoma","volume":"577","author":"Cabrita","year":"2020","journal-title":"Nature"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1016\/j.jaci.2022.05.021","article-title":"Retinoic acid promotes fibrinolysis and may regulate polyp formation","author":"Sakashita","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1038\/nature21349","article-title":"Elements of cancer immunity and the cancer\u2013immune set point","volume":"541","author":"Chen","year":"2017","journal-title":"Nature"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.61.1509","article-title":"Immunology and immunotherapy of head and neck cancer","volume":"33","author":"Ferris","year":"2015","journal-title":"J Clin Oncol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1652433","article-title":"Intratumoral bacterial load and tertiary lymphoid structure density in hepatocellular carcinoma: association and prognostic significance","volume":"16","author":"Qu","year":"2025","journal-title":"Front Immunol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.jare.2025.11.070","article-title":"Identification of marginal zone B cells in head and neck cancer with immunomodulatory characteristics","author":"Bao","year":"2025","journal-title":"J Adv Res"},{"key":"B36","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/nrc3245","article-title":"The immune contexture in human tumours: impact on clinical outcome","volume":"12","author":"Fridman","year":"2012","journal-title":"Nat Rev Cancer"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2026.119529","article-title":"Nanoparticle-based strategies for immune modulation and reorganization in the tumor microenvironment to combat cancer cells","volume":"200","author":"Azhdarifam","year":"2026","journal-title":"BioMed Pharmacother"},{"key":"B38","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1186\/s12951-022-01476-9","article-title":"Nanoparticles mediated tumor microenvironment modulation: current advances and applications","volume":"20","author":"Raju","year":"2022","journal-title":"J Nanobiotechnology"},{"key":"B39","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1007\/s10142-025-01668-0","article-title":"CircNOX4 promotes proliferation and resistance by regulating the hsa-miR-6884-5p\/YWHAG Axis and ERK signaling pathway in cholangiocarcinoma","volume":"25","author":"Yan","year":"2025","journal-title":"Funct Integr Genomics"},{"key":"B40","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.tcb.2008.10.003","article-title":"The 14-3-3 proteins: integrators of diverse signaling cues that impact cell fate and cancer development","volume":"19","author":"Morrison","year":"2009","journal-title":"Trends Cell Biol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcdb.2011.09.001","article-title":"Structural basis of 14-3-3 protein functions","volume":"22","author":"Obsil","year":"2011","journal-title":"Semin Cell Dev Biol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2024.101938","article-title":"Exploring the role of disulfidptosis-related signatures in immune microenvironment, prognosis and therapeutic strategies of cervical cancer","volume":"44","author":"Jin","year":"2024","journal-title":"Transl Oncol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202301714","article-title":"YWHAG deficiency disrupts the EMT\u2010associated network to induce oxidative cell death and prevent metastasis","volume":"10","author":"Lee","year":"2023","journal-title":"Adv Sci (Weinh)"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202301343","article-title":"Exploring the role of m6A methylation regulators in glioblastoma multiforme and their impact on the tumor immune microenvironment","volume":"37","author":"Deng","year":"2023","journal-title":"FASEB J"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1186\/s12885-021-08777-6","article-title":"ER expression associates with poor prognosis in male lung squamous carcinoma after radical resection","volume":"21","author":"Yang","year":"2021","journal-title":"BMC Cancer"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-024-02349-x","article-title":"YWHAG promotes colorectal cancer progression by regulating the CTTN-Wnt\/\u03b2-catenin signaling axis","volume":"41","author":"Wang","year":"2024","journal-title":"Med Oncol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.4238\/2015.December.21.10","article-title":"Critical genes in head and neck squamous cell carcinoma revealed by bioinformatic analysis of gene expression data","volume":"14","author":"Wang","year":"2015","journal-title":"Genet Mol Res"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/j.archoralbio.2024.106090","article-title":"Dysregulation of a novel m6A regulator YWHAG is correlated with metastasis and poor prognosis in oral squamous cell carcinoma \u2013 A cross-sectional study","volume":"169","author":"Ramesh Kumar","year":"2025","journal-title":"Arch Oral Biol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1038\/onc.2011.284","article-title":"Overexpression of 14-3-3\u03b6 in cancer cells activates PI3K via binding the p85 regulatory subunit","volume":"31","author":"Neal","year":"2012","journal-title":"Oncogene"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1233085","article-title":"Exploring the dual role of B cells in solid tumors: implications for head and neck squamous cell carcinoma","volume":"14","author":"Bao","year":"2023","journal-title":"Front Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1936961\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T05:35:54Z","timestamp":1789450554000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1936961\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,15]]},"references-count":50,"alternative-id":["10.3389\/fimmu.2026.1936961"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1936961","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,15]]},"article-number":"1936961"}}